We isolated at least 5 high-affinity A2/MART1 TCR clonotypes that recognized A2+ MART1+ tumor cells in a CD8-independent manner when expressed in CD4+ T cells (Fig. 6c). This evidence concerns the gene CD8A and neoplasm.